Clinical Trial Update: An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate [Phase 3]

View source ↗

Summary

Phase 3 study comparing sarilumab plus methotrexate to etanercept plus methotrexate in rheumatoid arthritis patients not responding to adalimumab plus methotrex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• KEVZARA (sarilumab)

Snippet

Sponsor: Sanofi | Conditions: Rheumatoid Arthritis | Phase 3 | Status: TERMINATED | Results posted: 2017-07-27